aflibercept
ItalyDrugs containing this active substance
-
Afqlir is injected into the eye to treat several eye diseases in adults, including age-related neovascular macular degeneration (exudative AMD), macular edema due to retinal vein occlusion (RVO) or diabetes (DME), and myopic choroidal neovascularization (myopic CNV).
Form: solution for injection
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: SANDOZ GMBH
-
This medicine is injected into the eye to treat several eye diseases in adults, including age-related neovascular macular degeneration (exudative AMD), macular edema caused by retinal vein occlusion or diabetes, and myopic choroidal neovascularization.
Form: solution for injection
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: FORMYCON AG
-
This medicine is injected into the eye to treat several vision diseases in adults, including age-related neovascular macular degeneration, macular edema caused by retinal vein occlusion or diabetes, and myopic choroidal neovascularization.
Form: solution for injection
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: FORMYCON AG
-
Eiyzey is used in adults to treat several eye diseases, including age-related neovascular macular degeneration (exudative AMD), macular edema due to retinal vein occlusion (RVO) or diabetes (DME), and myopic choroidal neovascularization (myopic CNV).
Form: solution for injection in pre-filled syringe
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: ZAKLADY FARMACEUTYCZNE POLPHARMA SA
-
This medicine is injected into the eye to treat several eye diseases in adults, including age-related neovascular macular degeneration (exudative AMD), macular edema due to retinal vein occlusion (RVO) or diabetes (DME), and myopic choroidal neovascularization (myopic CNV).
Form: solution for injection in pre-filled syringe
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: CELLTRION HEALTHCARE HUNGARY KFT
-
Eylea is injected into the eye to treat several eye diseases in adults, including age-related neovascular macular degeneration (exudative AMD), macular edema due to retinal vein occlusion (RVO) or diabetes (DME), and myopic choroidal neovascularization (myopic CNV). In premature infants, it is used for retinopathy of prematurity (ROP).
Form: solution for injection
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: BAYER AG
-
This medicine is injected into the eye to treat several eye diseases in adults, including age-related neovascular macular degeneration (exudative AMD), macular edema due to retinal vein occlusion or diabetes, and myopic choroidal neovascularization.
Form: solution for injection
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: ADVANZ PHARMA LIMITED
-
Opuviz is used in adults to treat several eye diseases, including age-related neovascular macular degeneration (exudative AMD), macular edema due to retinal vein occlusion (RVO) or diabetes (DME), and myopic choroidal neovascularization (myopic CNV).
Form: solution for injection
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: SAMSUNG BIOEPIS NL B.V.
-
It is used in adults to treat several eye diseases, including age-related neovascular macular degeneration (exudative AMD), macular edema caused by retinal vein occlusion (RVO) or diabetes (DME), and myopic choroidal neovascularization.
Form: solution for injection in pre-filled syringe
Active substance Dosage aflibercept - ATC: S01LA05
Manufacturer: BIOSIMILAR COLLABORATIONS IRELAND LIMITED
-
It is used in adults to treat advanced colorectal cancer. It works by preventing the development of new blood vessels within the tumor to slow down or stop its growth.
Form: solution for infusion, concentrate
Active substance Dosage aflibercept - ATC: L01XX44
Manufacturer: SANOFI WINTHROP INDUSTRIE